|
2025
|
P/S
|
Veterinary vaccines; Veterinary pharmaceutical preparations for the prevention of infectious dise... |
|
|
P/S
|
Downloadable computer software for tracking and reporting of parvovirus outbreaks in canines; Dow... |
|
|
P/S
|
Veterinary preparations, namely a medicated feed additive in the form of a narrow-spectrum antibi... |
|
|
P/S
|
Veterinary preparations and pharmaceuticals, namely an antiemetic for treatment and prevention of... |
|
|
P/S
|
Veterinary preparations, namely medicated feed additive and narrow-spectrum antibiotic for the re... |
|
|
P/S
|
Veterinary preparations; Monoclonal antibody therapeutic treatment of atopic dermatitis in dogs |
|
|
P/S
|
Veterinary preparations; Monoclonal antibody therapeutic treatment of atopic dermatitis in dogs; ... |
|
|
P/S
|
Veterinary pharmaceutical preparations for the treatment of atopic dermatitis in dogs |
|
|
P/S
|
Veterinary preparations; veterinary pharmaceuticals; Dietetic food and substances adapted for vet... |
|
|
P/S
|
Animal feed Veterinary preparations for companion animals, namely, to treat parasitic infections,... |
|
|
P/S
|
Animal feed Non-medicated additives for animal feed for use as nutritional supplements Providing ... |
|
2024
|
Invention
|
Porcine reproductive and respiratory syndrome vaccine virus.
The present invention relates to mo... |
|
|
P/S
|
Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the... |
|
|
Invention
|
Process for making an isoxazoline compound and intermediate thereof. The present disclosure provi... |
|
|
P/S
|
Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, e... |
|
|
P/S
|
Animal feed; Veterinary preparations for companion animals, namely, to treat parasitic infections... |
|
|
P/S
|
Animal feed; non-medicated supplements for animal feeds and additives Veterinary preparations for... |
|
|
Invention
|
Igg fc variants for veterinary use.
Provided are various embodiments relating to variant IgG Fc ... |
|
|
P/S
|
Veterinary preparations, namely dewormers and antiparasitic preparations for use on pets and dome... |
|
|
P/S
|
Veterinary preparations, namely, dewormers and antiparasitic preparations for use on pets and dom... |
|
|
P/S
|
Non-medicated grooming preparations for pets, namely, shampoos and conditioners Pharmaceutical pr... |
|
|
Invention
|
Formulations for bovine granulocyte colony stimulating factor and variants thereof.
This inventi... |
|
|
Invention
|
Technologies for measuring greenhouse gas emissions in ruminants following administration of feed... |
|
|
Invention
|
Methods for measuring greenhouse gas emissions in ruminants following administration of feed addi... |
|
|
P/S
|
Nutritional feed supplements for animals, namely, swine. |
|
|
P/S
|
Pest control preparations to control pests associated with pets; pest control preparations to con... |
|
|
P/S
|
Veterinary preparations; medicated feed additives for use in animals |
|
|
Invention
|
Stable salmonella vaccine formulations. The present disclosure provides formulations, kits, and v... |
|
|
P/S
|
Veterinary nutritional supplement for companion animals |
|
|
P/S
|
Veterinary nutritional supplement for companion animals |
|
|
Invention
|
Systems and methods for risk assessment for zoonotic disease in animal populations. Systems and m... |
|
|
P/S
|
Nutritional feed supplements for animals, namely, swine |
|
|
Invention
|
Il4/il13 receptor molecule for veterinary use.
Provided are various embodiments relating to IL13... |
|
2023
|
Invention
|
Compositions and methods for improved utilization of non-digestible fiber in animals. The present... |
|
|
Invention
|
Methods and formulations for reducing bovine emissions.
The present disclosure provides methods ... |
|
|
Invention
|
Salmonella vaccine compositions and methods thereof. The present disclosure provides compositions... |
|
|
Invention
|
Guanylate cyclase (gc) stimulator formulations and uses thereof. Formulations comprising a guanyl... |
|
|
Invention
|
Compositions and methods for improving hen welfare with beta-mannanase and probiotics. The presen... |
|
|
Invention
|
Therapeutic clay compositions and methods of using. The present invention provides methods of imp... |
|
|
Invention
|
Antimicrobial clay compositions and methods of using.
The present invention provides antimicrobi... |
|
|
Invention
|
Shroud device.
The disclosed embodiments include a protective housing for a fragile article for ... |
|
|
Invention
|
Compositions and methods to improve calf growth and reduce incidence of scours. The present discl... |
|
|
Invention
|
Erythropoietin and analogs for veterinary use.
Provided are various embodiments relating to feli... |
|
|
Invention
|
Methods for predicting efficacy of a modified live porcine reproductive and respiratory syndrome ... |
|
|
Invention
|
Anti-il31 antibodies for veterinary use.
Provided are various embodiments relating to anti-IL31 ... |
|
|
Invention
|
Chimeric canine anti-cd20 antibody. The disclosure relates to caninized chimeric anti-CD20 antibo... |
|
|
Invention
|
Winged capsule devices and methods. Exemplary winged capsules for delivery of a substance to an a... |
|
|
Invention
|
Feed additive compositions. The present disclosure provides feed composition comprising at least ... |
|
|
Invention
|
Methods, compositions, and food additives combining a f4/f18 vaccine and β-mannanase and/or a pro... |
|
|
Invention
|
Porcine g-csf variants and their uses. The present invention relates to variants of porcine granu... |
|
2022
|
Invention
|
Modified bovine g-csf polypeptides and their uses.
Modified bovine G-CSF polypeptides and uses t... |
|
|
Invention
|
Methods of improving the nutritional status of immune stressed animals.
Disclosed are compositio... |
|
|
Invention
|
Methods of improving the nutritional status of immune stressed animals. Disclosed are composition... |
|
|
Invention
|
Topical administration of composition comprising 10% w/v imidacloprid and 1% w/v moxidectin for t... |
|
|
Invention
|
Stable formulations of buprenorphine.
Methods of providing pain relief to animals, for example c... |
|
|
Invention
|
Stable formulations of buprenorphine. Methods of providing pain relief to animals, for example ca... |
|
|
Invention
|
Stable formulations of buprenorphine. A formulation comprising buprenorphine or salt thereof and ... |
|
|
Invention
|
Molidustat formulations and methods of use for treatment of anemia in cats.
Pharmaceutical compo... |
|
|
Invention
|
Molidustat formulations and methods of use for treatment of anemia in cats. Pharmaceutical compos... |
|
|
Invention
|
Method for improving growth performance in feedlot cattle. Disclosed a method of improving growth... |
|
|
Invention
|
Process for making diaryl isoxazoline derivative.
The present disclosure provides processes for ... |
|
|
Invention
|
Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, the causative agen... |
|
|
Invention
|
Crystalline forms of isoxazoline compound.
The present disclosure provides crystalline forms of ... |
|
2021
|
Invention
|
Jak inhibitors having a specific particle size distribution.
The present disclosure provides com... |
|
|
Invention
|
Palatable formulations.
Palatable oral dosage formulations are provided including an effective a... |
|
|
Invention
|
Process for making an isoxazoline compound and intermediate thereof.
The present disclosure prov... |
|
|
Invention
|
Il4/il13 receptor molecules for veterinary use.
Provided are various embodiments relating to IL1... |
|
|
Invention
|
Long-acting anti-il31 antibodies for veterinary use.
Provided are various embodiments relating t... |
|
|
Invention
|
Anti-il4 receptor antibodies for veterinary use.
Provided are various embodiments relating to an... |
|
2020
|
Invention
|
Microbial treatment.
The present disclosure relates to methods, compositions, and uses of a baci... |
